Skip to main content
Qualigen Therapeutics, Inc. logo

Qualigen Therapeutics, Inc. — Investor Relations & Filings

Ticker · QLGN ISIN · US74754R1032 US Professional, scientific and technical activities
Open in API
Filings indexed 618 across all filing types
Latest filing 2017-12-20 Declaration of Voting R…
Country US United States of America
Listing US QLGN

About Qualigen Therapeutics, Inc.

https://qlgntx.com/

Qualigen Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel treatments for cancer. The company's efforts are directed toward creating therapeutics for both adult and pediatric patients, with a particular emphasis on rare cancers and areas of high unmet medical need. Its development approach combines internal capabilities with collaborations from major cancer research institutions. The company's investigational oncology pipeline includes programs such as QN-302, a Pan-RAS inhibitor platform, and QN-247.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The content specifically details the submission of matters to a vote of security holders at a special meeting, including the voting results for proposals related to a reverse stock split and adjournment authority. This matches the description of Declaration of Voting Results & Voting Rights Announcements (DVA). The document is about voting results, not a full annual or quarterly report, nor a proxy solicitation or management discussion. The length is 4093 characters, which is consistent with a detailed voting results announcement. Therefore, the correct classification is DVA with high confidence.
2017-12-20 English
Regulatory Filings 2017
Regulatory Filings Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content discusses a Nasdaq listing compliance issue, specifically the company's failure to meet the minimum bid price requirement and the steps taken to regain compliance, including a recent public offering to increase stockholders' equity. This is a typical subject for an 8-K filing, which is a regulatory filing to disclose significant events but is not a full financial report like an Annual Report (10-K) or Quarterly Report (IR). The document is not a certification or a proxy statement, nor is it a presentation or earnings release. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings like Form 8-K that do not fit other specific categories.
2017-12-01 English
Proxy Solicitation & Information Statement 2017
Proxy Solicitation & Information Statement
2017-12-01 English
SC 13D/A Filing
Major Shareholding Notification
2017-11-28 English
Proxy Solicitation & Information Statement 2017
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A proxy statement filed with the SEC, as indicated by the header and the text referencing the Securities Exchange Act of 1934 and Rule 14a-101. It is a proxy statement for a Special Meeting of Stockholders of Ritter Pharmaceuticals, Inc., discussing proposals such as a reverse stock split and adjournment authority. The document includes detailed information about the meeting, voting procedures, and board recommendations. This matches the definition of a Proxy Solicitation & Information Statement (PSI), which are materials sent to shareholders to provide information and request votes for meetings. The document is not an announcement of a report, nor is it a full financial report or earnings release. Therefore, the correct classification is PSI with high confidence.
2017-11-07 English
Interim / Quarterly Report 2017
Interim / Quarterly Report Q3 2017
2017-10-31 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.